Stefano Fontana, Simone Braggio, Mauro Corsi, Rob Riley, Chris Strock, Jenifer Bradley, Caterina Virginio & Paul Walker. 2023. The Handbook of Medicinal Chemistry. The Handbook of Medicinal Chemistry
533
596
.
Nupur Vasdev, Mrudul Deshpande, Pratik Katare, Vaishali Makwana, Suryanarayana Polaka, Muktika Tekade, Pinaki Sengupta, Mukesh Chandra Sharma, Dinesh Kumar Mishra & Rakesh Kumar Tekade. 2022. Pharmacokinetics and Toxicokinetic Considerations. Pharmacokinetics and Toxicokinetic Considerations
175
219
.
Nadine Dreser, Katrin Madjar, Anna-Katharina Holzer, Marion Kapitza, Christopher Scholz, Petra Kranaster, Simon Gutbier, Stefanie Klima, David Kolb, Christian Dietz, Timo Trefzer, Johannes Meisig, Christoph van Thriel, Margit Henry, Michael R. Berthold, Nils Blüthgen, Agapios Sachinidis, Jörg Rahnenführer, Jan G. Hengstler, Tanja Waldmann & Marcel Leist. (2019) Development of a neural rosette formation assay (RoFA) to identify neurodevelopmental toxicants and to characterize their transcriptome disturbances. Archives of Toxicology 94:1, pages 151-171.
Crossref
Aneesh Chandrasekharan, Shankara Narayanan Varadarajan, Asha Lekshmi, Santhik Subhasingh Lupitha, Pramod Darvin, Leena Chandrasekhar, Prakash Rajappan Pillai, T.R. Santhoshkumar & M. Radhakrishna Pillai. (2019) A high-throughput real-time in vitro assay using mitochondrial targeted roGFP for screening of drugs targeting mitochondria. Redox Biology 20, pages 379-389.
Crossref
Douglas M. Ruden, Katherine Gurdziel & Michael Aschner. (2017) Frontiers in Toxicogenomics in the Twenty-First Century—the Grand Challenge: To Understand How the Genome and Epigenome Interact with the Toxic Environment at the Single-Cell, Whole-Organism, and Multi-Generational Level. Frontiers in Genetics 8.
Crossref
J. Nicolette. 2017. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development
129
154
.
Ching-Hung Hsu & Qingli Wang. 2015. Hamilton & Hardy's Industrial Toxicology. Hamilton & Hardy's Industrial Toxicology
1173
1188
.
Federica Madia, Pascal Phrakonkham & Raffaella Corvi. 2014. In Vitro Toxicology Systems. In Vitro Toxicology Systems
307
332
.
John Nicolette. 2013. A Comprehensive Guide to Toxicology in Preclinical Drug Development. A Comprehensive Guide to Toxicology in Preclinical Drug Development
141
166
.
Richard M. Walmsley & Matthew Tate. 2012. Genetic Toxicology. Genetic Toxicology
231
250
.
M. S. Mondal, J. Gabriels, C. McGinnis, M. Magnifico, T. H. Marsilje, L. Urban, A. Collis, D. Bojanic, S. A. Biller, W. Frieauff, H.-J. Martus, W. Suter & P. Bentley. (2010) High-Content Micronucleus Assay in Genotoxicity Profiling: Initial-Stage Development and Some Applications in the Investigative/Lead-Finding Studies in Drug Discovery. Toxicological Sciences 118:1, pages 71-85.
Crossref
Louise Birrell, Paul Cahill, Chris Hughes, Matthew Tate & Richard M. Walmsley. (2010) GADD45a-GFP GreenScreen HC assay results for the ECVAM recommended lists of genotoxic and non-genotoxic chemicals for assessment of new genotoxicity tests. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 695:1-2, pages 87-95.
Crossref
Christa Baumstark-Khan, Christine E. Hellweg & Günther Reitz. 2010. Whole Cell Sensing System II. Whole Cell Sensing System II
113
151
.
Steven O. Simmons, Chun-Yang Fan & Ram Ramabhadran. (2009) Cellular Stress Response Pathway System as a Sentinel Ensemble in Toxicological Screening. Toxicological Sciences 111:2, pages 202-225.
Crossref
Paul W. Hastwell, Thomas W. Webster, Matthew Tate, Nicholas Billinton, Anthony M. Lynch, James S. Harvey, Robert W. Rees & Richard M. Walmsley. (2009) Analysis of 75 marketed pharmaceuticals using the GADD45a-GFP ‘GreenScreen HC’ genotoxicity assay. Mutagenesis 24:5, pages 455-463.
Crossref
Richard M. Walmsley & Nicholas Billinton. (2009) Genotoxic carcinogen or not genotoxic carcinogen? That is the question. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 672:1, pages 17-19.
Crossref